Monoclonal antibodies to inhibit Aspergillus germination

  • Feldmesser, Marta (PI)

Project: Research project

Project Details

Description

Aspergillus fumigatus, a ubiquitous fungal pathogen, causes invasive disease in severely
immunocompromised patients, most often in those with profound neutropenia or who have undergone organ
transplantation. The incidence of invasive aspergillosis (IA) has risen steadily over the past three decades,
and mortality rates currently range from 45-90%. The goal of this proposal is to advance our understanding
of host immunity and host-pathogen interactions in invasive aspergillosis using a monoclonal antibody (MAb
318) that inhibits germination, the phase transition from the spore form to hyphal form that is required for
invasion, and prolongs survival in mice with invasive pulmonary aspergillosis. Germination-inhibitory MAbs
potentially could be developed for use as immunoprophylactic or diagnostic agents. MAb immunotherapy is
being applied with increasing success not only to treatment of refractory or resistant microbial pathogens, but
to disease states as diverse as malignancy, asthma and autoimmune disorders. Additionally, identification of
fungal molecules bound by protective MAbs may define novel targets for drug development. Three specific
aims are proposed: 1. To identify the protein bound by MAb 318 and determine the kinetics of its
expression during germination;2. Tounderstand the interaction between conidia and MAb 318 in vitro in
the presence and absence of alveolar macrophages;3. Tounderstand the mechanism of protective efficacy
of passively administered MAbs to the 50 kDa antigen. It is anticipated that this study will identify fungal
molecules important for germination and begin to define their interaction with host immune responses.
StatusFinished
Effective start/end date2/1/061/31/12

Funding

  • National Institute of Allergy and Infectious Diseases: $372,563.00
  • National Institute of Allergy and Infectious Diseases: $391,357.00
  • National Institute of Allergy and Infectious Diseases: $395,309.00
  • National Institute of Allergy and Infectious Diseases: $395,309.00
  • National Institute of Allergy and Infectious Diseases: $362,669.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.